LOVELAND, Colo., July 11, 2017 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA) - (News; "Heska" or the "Company"),a provider of advanced veterinary diagnostic and specialty products, plans to announce its second quarter 2017 financial results in a press release to be issued on Monday, July 31, 2017 before the market opens. The Company
To access the conference call:
From within the United States, please dial 1-888-539-3624From outside of the United States, please dial 1-719-325-2468Reference Conference ID: 9569010
The conference call will be webcast live from the Company's website on www.heska.com.
A telephonic replay of the conference call will be available beginning at 2 p.m. ET and continue through 11:59 p.m. ET on Monday, August 7, 2017.
To access the replay:
From within the United States, please dial 1-844-512-2921From outside the United States, please dial 1-412-317-6671Reference Replay Pin Number: 9569010
The webcast will also be archived on www.heska.com for 90 days.
About HeskaHeska Corporation (NASDAQ: HSKA - News) sells advanced veterinary diagnostic and specialty products. Heska's state-of-the-art offerings include blood testing instruments and supplies, digital imaging products, software and services, vaccines, local and cloud-based data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The Company's core focus is on supporting veterinarians in the canine and feline healthcare space. For further information on Heska and its products, visit www.heska.com.
View original content:http://www.prnewswire.com/news-releases/heska-schedules-second-quarter-2017-financial-results-conference-call-for-july-31-2017-300485677.html
SOURCE Heska Corporation
Subscribe to our Free Newsletters!
Lazy eye or amblyopia occurs when sight in one eye is less than the other in early childhood due to ...
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...View All